You are here: Home » Government Press Release » News
Business Standard

Coded formulation AYUSH-QOL-2C developed to minimize side effects of Chemo and radiotherapy in Cancer patients: Shri Shripad Yesso Naik

Delhi 

Coded formulation AYUSH-QOL-2C developed to minimize side effects of Chemo and radiotherapy in patients: Shri Shripad Yesso Naik

The Central Council for Research in Ayurvedic Sciences (CCRAS) has developed an anti-diabetic drug AYUSH-82. License has been granted to eight firms through National Research Development Corporation (NRDC) for commercialization.

CCRAS has developed a coded formulation AYUSH-QOL-2C to minimize side effects of Chemo and radiotherapy to improve quality of life in patients. The Central Council for Research in Homoeopathy (CCRH) has undertaken study to assess usefulness of Homoeopathic medicine in patients having side effects from Chemotherapy. The Central Council for Research in Yoga and Naturopathy (CCRYN) organises Yoga and Diabetes awareness programme through Government and Non-Government organizations.

This information was given by the Minister of State (Independent Charge) for AYUSH, Shri ShripadYesso Naik in written reply to a question in Rajya Sabha today.

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

RECOMMENDED FOR YOU

Coded formulation AYUSH-QOL-2C developed to minimize side effects of Chemo and radiotherapy in Cancer patients: Shri Shripad Yesso Naik

Coded formulation AYUSH-QOL-2C developed to minimize side effects of Chemo and radiotherapy in Cancer patients: Shri Shripad Yesso Naik
Coded formulation AYUSH-QOL-2C developed to minimize side effects of Chemo and radiotherapy in patients: Shri Shripad Yesso Naik

The Central Council for Research in Ayurvedic Sciences (CCRAS) has developed an anti-diabetic drug AYUSH-82. License has been granted to eight firms through National Research Development Corporation (NRDC) for commercialization.

CCRAS has developed a coded formulation AYUSH-QOL-2C to minimize side effects of Chemo and radiotherapy to improve quality of life in patients. The Central Council for Research in Homoeopathy (CCRH) has undertaken study to assess usefulness of Homoeopathic medicine in patients having side effects from Chemotherapy. The Central Council for Research in Yoga and Naturopathy (CCRYN) organises Yoga and Diabetes awareness programme through Government and Non-Government organizations.

This information was given by the Minister of State (Independent Charge) for AYUSH, Shri ShripadYesso Naik in written reply to a question in Rajya Sabha today.

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

image
Business Standard
177 22

Coded formulation AYUSH-QOL-2C developed to minimize side effects of Chemo and radiotherapy in Cancer patients: Shri Shripad Yesso Naik

Coded formulation AYUSH-QOL-2C developed to minimize side effects of Chemo and radiotherapy in patients: Shri Shripad Yesso Naik

The Central Council for Research in Ayurvedic Sciences (CCRAS) has developed an anti-diabetic drug AYUSH-82. License has been granted to eight firms through National Research Development Corporation (NRDC) for commercialization.

CCRAS has developed a coded formulation AYUSH-QOL-2C to minimize side effects of Chemo and radiotherapy to improve quality of life in patients. The Central Council for Research in Homoeopathy (CCRH) has undertaken study to assess usefulness of Homoeopathic medicine in patients having side effects from Chemotherapy. The Central Council for Research in Yoga and Naturopathy (CCRYN) organises Yoga and Diabetes awareness programme through Government and Non-Government organizations.

This information was given by the Minister of State (Independent Charge) for AYUSH, Shri ShripadYesso Naik in written reply to a question in Rajya Sabha today.

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

image
Business Standard
177 22

Upgrade To Premium Services

Welcome User

Business Standard is happy to inform you of the launch of "Business Standard Premium Services"

As a premium subscriber you get an across device unfettered access to a range of services which include:

  • Access Exclusive content - articles, features & opinion pieces
  • Weekly Industry/Genre specific newsletters - Choose multiple industries/genres
  • Access to 17 plus years of content archives
  • Set Stock price alerts for your portfolio and watch list and get them delivered to your e-mail box
  • End of day news alerts on 5 companies (via email)
  • NEW: Get seamless access to WSJ.com at a great price. No additional sign-up required.
 

Premium Services

In Partnership with

 

Dear Guest,

 

Welcome to the premium services of Business Standard brought to you courtesy FIS.
Kindly visit the Manage my subscription page to discover the benefits of this programme.

Enjoy Reading!
Team Business Standard